APA (7th ed.) Citation

Haraguchi Hashiguchi, M., Tanino, M., Yoneda, S., Asaoka, M., Kagyo, J., Katayama, M., . . . Fukunaga, K. (2025). Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion. Thoracic Cancer, 16(20), 1. https://doi.org/10.1111/1759-7714.70176

Chicago Style (17th ed.) Citation

Haraguchi Hashiguchi, Mizuha, et al. "Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion." Thoracic Cancer 16, no. 20 (2025): 1. https://doi.org/10.1111/1759-7714.70176.

MLA (9th ed.) Citation

Haraguchi Hashiguchi, Mizuha, et al. "Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion." Thoracic Cancer, vol. 16, no. 20, 2025, p. 1, https://doi.org/10.1111/1759-7714.70176.